topotecan hydrochloride 4 mg / 4mL Injection 4 mL
Comprehensive product details for sourcing and verification.
| NDC 11 | 16729-0151-31 |
|---|---|
| Product NDC | 16729-0151 |
| Generic Drug Name | topotecan hydrochloride |
| Brand Name | topotecan hydrochloride |
| Manufacturer | Accord Healthcare, Inc. |
| Strength | 4 mg / 4mL |
| Dosage Form | Injection |
| Drug Type | Intravenous |
| Package Quantity | 1 Vial |
| Package Description | 1 VIAL in 1 PACKAGE (16729-151-31) / 4 mL in 1 VIAL |
| Active Ingredients | Topotecan Hydrochloride |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
topotecan hydrochloride 4 mg / 4mL Injection is tracked under NDC 16729-0151-31 and rolls up into product family 16729-0151. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 1 Vial.
- Manufacturer: Accord Healthcare, Inc..
- Dosage form: Injection.
- Family size: 1 active presentation.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Drug Shortage Information
Public sources include one exact NDC package reference, one current official label reference, and one FDA recall notice relevant to the product’s public history.
Drug Shortage Index family
View Topotecan hydrochloride in the Drug Shortage IndexCompare related exact NDC products and family-level shortage context for Topotecan hydrochloride.This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
topotecan hydrochloride 4 mg / 4mL Injection 4 mL, NDC 16729-0151-31, is a Accord Healthcare, Inc. 4 mg / 4mL injection presentation packaged as 1 Vial. Historical public shortage information is available for this exact presentation.
NDC search formats
- Canonical NDC 11: 16729-0151-31.
- Digits-only NDC 11: 16729015131.
- Possible 10-digit display format: 16729-151-31 (1672915131).
Helpful product links
- Search by brand name: topotecan hydrochloride.
- Exact NDC 11: 16729-0151-31.
- Product family NDC: 16729-0151.
Related shortage research
If your team is researching the broader shortage picture, the family page groups related exact NDC items, brand variations, and family-level shortage context in one place.